Subscribe to our mailing list
Get
Amongst It
Get
Amongst It
Jun 23
2015
*UPDATE* Please see the updated documents, this action has turned into a Class Action Interim Injunction. |
If enough people try to sue the government all at once…. using this form below, it could become a “class action” lawsuit against the government. If you want to join the class action, please enter your email in the subscribe box on this page (legalise.org.nz/prosecute-moh)
Download PDF Â Â | Download Doc
IN THE DISTRICT COURT                                               CRI–2014-xxx-xxxxx
HELD AT [REDACTED]
Â
IN THE MATTER                       of breach of Section 3A of The Health Act 1956 in regards to the Function of Ministry in relation to public health; by failure to carry out it’s core founding function of improving, promoting, and protecting public health in relation to Cannabis.
Â
IN THE MATTER                       of removing, in it’s capacity of administration of the act, and due to overwelming evidence in support of the medicinal use of Cannabis Sativa and it’s variant straings, all mention of Cannabis plant and extracts in any schedule of the Misuse of Drugs Act 1975, an act which is solely administered by the Ministry of Health.
AND IN THE MATTER Â Â Â Â Â Â Â Â Â Â Â Â Â Â of contravention of part 2 section 17 of the NZ Bill of Rights Act 1990 in relation to Freedom of thought, conscience, and religion. Namely that everyone has the right to freedom of thought, conscience, religion, and belief, including the right to adopt and to hold opinions without interference.
Â
AND IN THE MATTER Â Â Â Â Â Â Â Â Â Â Â Â Â Â of contravention of article 24, clause 1 of the UN Declaration on The Rights of Indigeonous Peoples 2007; expressly that Indigenous peoples have the right to their traditional medicines and to maintain their health practices, including the conservation of their vital medicinal plants, animals and minerals. Indigenous individuals also have the right to access, without any discrimination, to all social and health services.
AND IN THE MATTER               of the resulting financial, physiological and psychological damages arising from punishments out of all proportion to the “crimes†commited, and resulting from the lack of access to appropriate herbal medicine
BETWEEN Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â [REDACTED]
Applicant
AND Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CHAI CHUAH
DIRECTOR-GENERAL MINISTRY OF HEALTH
Respondent
AND Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â LT GEN RT HON SIR JERRY MATEPARAE
THE GOVERNOR GENERAL
Respondent
AND Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â JONATHAN DAVID COLEMAN
THE MINISTER OF HEALTH
Â
Â
Â
AFFIDAVIT OF [REDACTED]
IN SUPPORT OF THE PRIVATE PROSECUTION
SWORN this                       June 2015
For hearing                   June 2015
Respondents contact details:
SOLICITOR:Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â COUNSEL:
[REDACTED]Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â [REDACTED]
Table of contents
Declaration…………………………………………………………………………………………… 2
Incorrect Classification of Drug Schedules…………………………………………………. 2
Appendix of Evidence……………………………………………………………………………. 4
Expert Advisory Committee on Drugs give a high priority to its reconsideration of the classification of cannabis.      4
Inquiry into the public health strategies related to cannabis use and the most appropriate legal status – Report of the Health Committee.  4
Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells         4
Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells         4
THC Shrinks Tumours……………………………………………………………………………… 4
Emerging Clinical Applications for Cannabis & Cannabinoids………………………. 4
Minister Peter Dunne approves one-off use of Cannabidiol product ‘Elixinol’…… 4
Â
I, [REDACTED], Â SWEAR as follows:
Â
SWORN at [REDACTED] by                                           )
[REDACTED] Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â )
this      day of  June    2015                            )
before me: Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â )
A Barrister & Solicitor of the High Court of New Zealand
Registrar/ Deputy Registrar
Justice of the Peace
Â
Â
Â
Â
Page 49-50 of DBSCH-SCR-2531-2399.pdf*
Â
Page 57 of DBSCH-SCR-2531-2399.pdf*
Â
* Forty-seventh Parliament (Steve Chadwick, Chairperson) August 2003
Â
Guillermo Velasco, Complutense University, Madrid, Spain. 2009.
Â
Salazar et al. Journal of Clinical Investigation, 2009;
DOI: 10.1172/JCI37948.
Â
Munsen A.E et al. J Nat Cancer Inst, Vol 55, No. 3, Sept 1975.
Â
A 2009 review of nearly 200 scientific trials assessing the therapeutic utility of cannabinoids for the treatment of nineteen clinical indications: Alzheimer’s disease, ALS, chronic pain, diabetes mellitus, dystonia, fibromyalgia, gastrointestinal disorders, gliomas, hepatitis C, HIV, hypertension, incontinence, MRSA, multiple sclerosis, arthritis, sleep apnoea, and Tourette’s syndrome.
Â
9 June 2015 Beehive Press Release https://www.beehive.govt.nz/release/minister-approves-one-use-cannabidiol-product-%E2%80%98elixinol%E2%80%99
Associate Minister of Health Hon Peter Dunne has today approved on compassionate grounds the one-off use of Elixinol, a cannabidiol (CBD) product from the United States to be administered by clinicians treating Wellington patient Alex Renton.
…
“I have also considered the absence of any other treatment options, the low risk of significant adverse effects, and the conclusion reached by the hospital ethics committee from an individual patient perspective.â€